Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV002249538 | SCV002518981 | pathogenic | Moyamoya disease 2 | 2022-05-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003727830 | SCV004539086 | uncertain significance | not provided | 2023-06-20 | criteria provided, single submitter | clinical testing | This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 2057 of the RNF213 protein (p.Asp2057Asn). This variant is present in population databases (rs768740459, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with RNF213-related conditions. ClinVar contains an entry for this variant (Variation ID: 684683). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Yale Center for Mendelian Genomics, |
RCV000845199 | SCV000987135 | likely pathogenic | Atypical coarctation of aorta | 2018-02-26 | no assertion criteria provided | literature only |